EUVIMEDEUVIMED entdecken
Crossref

Activatable Hypoxia Magnetic Resonance Imaging for Early Stratification of Radiotherapy Response

Mingkun Wang, Xiaoming Liu, Guoao Dong, Weilin Chen, Changrong Shi, Xinyi Zhang, Ao Li, Zijian Zhou, Yixi Wang, Hong-Yi Yang, Fantian Zeng

Nanoscale Horizons · 2026

DOI: 10.1039/d6nh00371k ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale Horizons, 2026. Verfasst von Mingkun Wang und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor hypoxia is a major cause of radioresistance and heterogeneous outcomes in radiotherapy (RT). Noninvasive strategies capable of quantifying tumor hypoxia prior to treatment are essential for precision radiotherapy and...

Zitieren

APA

Wang, M., Liu, X., Dong, G., Chen, W., Shi, C., Zhang, X., Li, A., Zhou, Z., Wang, Y., Yang, H., & Zeng, F. (2026). Activatable Hypoxia Magnetic Resonance Imaging for Early Stratification of Radiotherapy Response. Nanoscale Horizons. https://doi.org/10.1039/d6nh00371k

Vancouver

Wang M, Liu X, Dong G, Chen W, Shi C, Zhang X, et al. Activatable Hypoxia Magnetic Resonance Imaging for Early Stratification of Radiotherapy Response. Nanoscale Horizons. 2026. doi:10.1039/d6nh00371k

BibTeX
@article{Wang2026,
  author = {Wang, Mingkun and Liu, Xiaoming and Dong, Guoao and Chen, Weilin and Shi, Changrong and Zhang, Xinyi and Li, Ao and Zhou, Zijian and Wang, Yixi and Yang, Hong-Yi and Zeng, Fantian},
  title = {Activatable Hypoxia Magnetic Resonance Imaging for Early Stratification of Radiotherapy Response},
  journal = {Nanoscale Horizons},
  year = {2026},
  doi = {10.1039/d6nh00371k}
}
Kostenlos starten →